skip to content
Primary navigation


DrugKhedezla (desvenlafaxine, extended-release)

June 2014

Therapeutic area - Antidepressant

Approval criteria

  • Provider provides a compelling clinical reason why the new salt formulation will provide superior clinical efficacy than the original active ingredient and formulation AND
  • Patient has tried and failed venlafaxine, 2 SSRI's, and Pristiq


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top